about
Restrictive and diversifying elements of the anti-myelin/oligodendrocyte glycoprotein antibody response in primate experimental allergic encephalomyelitis.Molecular characterization of antibody specificities against myelin/oligodendrocyte glycoprotein in autoimmune demyelinationRituximab efficiently depletes increased CD20-expressing T cells in multiple sclerosis patients.A Haystack Heuristic for Autoimmune Disease Biomarker Discovery Using Next-Gen Immune Repertoire Sequencing DataImmunoglobulin class-switched B cells form an active immune axis between CNS and periphery in multiple sclerosis.Antibodies to native myelin oligodendrocyte glycoprotein are serologic markers of early inflammation in multiple sclerosis.Update on the autoimmune pathology of multiple sclerosis: B-cells as disease-drivers and therapeutic targetsConformational epitopes of myelin oligodendrocyte glycoprotein are targets of potentially pathogenic antibody responses in multiple sclerosis.Pathogen specificity and autoimmunity are distinct features of antigen-driven immune responses in neuroborreliosis.The myelin oligodendrocyte glycoprotein directly binds nerve growth factor to modulate central axon circuitry.B cell repertoire expansion occurs in meningeal ectopic lymphoid tissue.Accelerated remyelination during inflammatory demyelination prevents axonal loss and improves functional recoveryLong-term evolution of multiple sclerosis disability in the treatment era.In multiple sclerosis, oligoclonal bands connect to peripheral B-cell responses.B cells in multiple sclerosis: connecting the dots.Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis.Intravenous thrombolysis in stroke patients with hyperdense middle cerebral artery sign.Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis.[Statins for treatment of CNS diseases. Status report from research and clinical practice].Characterization of the expressed immunoglobulin IGHV repertoire in the New World marmoset Callithrix jacchus.Relevant antibody subsets against MOG recognize conformational epitopes exclusively exposed in solid-phase ELISA.Clemastine fumarate as a remyelinating therapy for multiple sclerosis (ReBUILD): a randomised, controlled, double-blind, crossover trial.Clonal relationships of CSF B cells in treatment-naive multiple sclerosis patients.Functional outcome and prevalence of recurrent ischemic events in patients with acute ischemic stroke due to aortic plaques.Clonally expanded plasma cells in the cerebrospinal fluid of patients with central nervous system autoimmune demyelination produce "oligoclonal bands".Following the tracks of immune responsesEarly recurrent ischemic stroke in stroke patients undergoing intravenous thrombolysisRotational vertebral artery syndrome: 3D kinematics of nystagmus suggest bilateral labyrinthine dysfunctionSerum cholesterol levels do not influence outcome or recovery in acute ischemic strokeGood outcomes in ischemic stroke patients treated with intravenous thrombolysis despite regressing neurological symptoms
P50
Q30810623-B6726D4F-357D-4CD4-A0B3-A9D747230D6FQ31076579-2276FA84-7E63-4AF4-A927-D699DEECEC40Q33849373-1D065643-B085-42E7-8463-8CFA565E9957Q33902773-6FF3AEC5-5236-4BDE-979F-41241BBE6E21Q34251673-5E0BE5C6-984A-411C-9AE1-591A0DEE1B2DQ34479121-8BE2546E-D54F-4FD3-BF40-3C1280F0846AQ35463552-C8DB6DD4-22A6-429B-989C-287A7EDF526BQ35614751-8D0B8CC8-3477-48AF-9C05-3C8A4C127F31Q35949765-EED733FC-CA46-419A-B091-3F76AE104B9DQ36078270-C05C9C27-1A01-418B-B6FA-A0A547B12B94Q36220292-0F5C5CD8-13D5-4D79-B723-E86ED2C05AC1Q37289783-43C549A9-7245-492B-BFF6-9C47D6677E6BQ37409279-63937D85-8226-4173-91E7-E47114ED57C7Q37652977-9C29AF50-D129-4AE8-A33A-7B0017814BD5Q37943607-C8F2BFA0-FF99-44FB-B918-7481B8579ABEQ41686940-D031CD52-1869-48B7-9A72-AB4E4522154AQ44025784-E9CB6579-2C0A-4E8A-AD54-BA03255734A8Q44111811-1AEE9F2D-CB90-41F2-A719-319C8B0AFD78Q45078529-38A2A365-4DEF-45B4-9D8D-5A0D206BE914Q46130100-1CC66CDE-B24E-40C7-AA07-3A1F34D1C0ABQ46390509-C22B4A28-E597-4B69-B904-985B000D47F9Q47243953-0809BDF1-5301-49BA-A87B-573A3299C365Q47935420-428A9DC4-5C3E-4C67-ACBD-1E11C9FB58EEQ48137978-A74AC10D-4EE3-426F-8D29-B98E4627BBECQ48412765-43063BF5-B663-4521-BCFF-E832BEFEAE39Q79086574-437C466F-C871-479B-BE3D-389F69EBCC65Q79873228-3DAFD7C4-D046-40DC-9509-5DE706BF79F9Q80701143-E1ECF0E8-9B46-4FD3-A9D6-C0970B11AB46Q80983716-5E6A6191-1754-4439-9F5D-0FA1331F224FQ82928161-A2B9C68D-A03E-4664-B5B2-0BA76EAD0027
P50
description
researcher
@en
wetenschapper
@nl
name
Hans-Christian von Büdingen
@en
Hans-Christian von Büdingen
@nl
type
label
Hans-Christian von Büdingen
@en
Hans-Christian von Büdingen
@nl
prefLabel
Hans-Christian von Büdingen
@en
Hans-Christian von Büdingen
@nl
P108
P106
P31
P496
0000-0003-0159-6662